Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Non-Current Assets (2023 - 2025)

Beta Bionics' Non-Current Assets history spans 3 years, with the latest figure at $60.8 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 263.82% year-over-year to $60.8 million; the TTM value through Dec 2025 reached $240.9 million, changed N/A, while the annual FY2025 figure was $60.8 million, 263.82% up from the prior year.
  • Non-Current Assets for Q4 2025 was $60.8 million at Beta Bionics, up from $60.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $76.1 million in Q1 2025 and bottomed at $6.4 million in Q4 2023.
  • The 3-year median for Non-Current Assets is $52.0 million (2025), against an average of $44.0 million.
  • The largest annual shift saw Non-Current Assets skyrocketed 160.51% in 2024 before it surged 263.82% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $6.4 million in 2023, then surged by 160.51% to $16.7 million in 2024, then soared by 263.82% to $60.8 million in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Non-Current Assets are $60.8 million (Q4 2025), $60.0 million (Q3 2025), and $43.9 million (Q2 2025).